ArticleThe Journal of infectious diseases2025
Risk Assessment of Oropouche Virus Transmission by Mosquitoes in Europe.
Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Low Generation Culex quinquefasciatus from Texas and Culex pipiens from New Jersey Are Incompetent Vectors for Oropouche Virus.The American journal of tropical medicine and hygiene · 2026Article
- Pediatric Arboviral Infections in Europe: Epidemiology, Clinical Features, Diagnosis and Prevention.Viruses · 2026Review
- Are mosquito species present in Spain competent for Oropouche virus?Parasites & vectors · 2026Article
- Oropouche virus: transmission, epidemiology, genetic diversity, and public health implications.EClinicalMedicine · 2026Review
- What are the vector species of the Oropouche virus?Pest management science · 2026Review
- Low risk of transmission of prototype and newly emerged Oropouche virus strains by European Culex pipiens, Aedes albopictus, and Anopheles atroparvus mosquitoes.PLoS neglected tropical diseases · 2026Article
- Sustained Oropouche virus transmission in Rio de Janeiro's Atlantic Forest: genomic evidence over a two-year period.Memorias do Instituto Oswaldo Cruz · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Oropouche virus (OROV) emerged as a significant health threat in Central and South America in 2024. Culicoides (Diptera: Ceratopogonidae) is considered the primary vector, while the role of mosquitoes in the transmission cycle is still unclear. This study evaluates the vector competence of 5 mosquito species common in Europe for OROV (old strain). While Culex torrentium, Culex pipiens biotype pipiens, Aedes aegypti, and Aedes japonicus showed no transmission, Aedes albopictus demonstrated low transmission at higher temperatures. Temperature-based risk analysis for areas with established A albopictus populations suggests that regions around the Mediterranean are at potential risk for OROV transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.